Evommune EVMN Loss On Issuance Of Preferred Stock Derivative Liability
Loss On Issuance Of Preferred Stock Derivative Liability at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:LossOnIssuanceOfPreferredStockDerivativeLiability.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's loss on issuance of preferred stock derivative liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's loss on issuance of preferred stock derivative liability?
- Evommune (EVMN) reported loss on issuance of preferred stock derivative liability of $6.31M in Q1 2026.
- How has Evommune 's loss on issuance of preferred stock derivative liability changed year-over-year?
- Evommune 's loss on issuance of preferred stock derivative liability increased by 376.8% year-over-year, from $1.32M to $6.31M.
- What does loss on issuance of preferred stock derivative liability mean?
- Measures the accounting loss recognized upon the initial issuance of preferred stock that contains embedded derivative features. This reflects the difference between the fair value of the liability and the proceeds received, highlighting the cost of complex capital structures.